AU8636798A - Pharmaceutical compounds isolated from aristolochia taliscana - Google Patents

Pharmaceutical compounds isolated from aristolochia taliscana

Info

Publication number
AU8636798A
AU8636798A AU86367/98A AU8636798A AU8636798A AU 8636798 A AU8636798 A AU 8636798A AU 86367/98 A AU86367/98 A AU 86367/98A AU 8636798 A AU8636798 A AU 8636798A AU 8636798 A AU8636798 A AU 8636798A
Authority
AU
Australia
Prior art keywords
pharmaceutical compounds
compounds isolated
aristolochia taliscana
taliscana
aristolochia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU86367/98A
Inventor
Hans Achenbach
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Proteome Sciences PLC
Original Assignee
Electrophoretics International PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Electrophoretics International PLC filed Critical Electrophoretics International PLC
Publication of AU8636798A publication Critical patent/AU8636798A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/78—Separation; Purification; Stabilisation; Use of additives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/753—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
    • C07C49/755—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups a keto group being part of a condensed ring system with two or three rings, at least one ring being a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/86—Benzo [b] furans; Hydrogenated benzo [b] furans with an oxygen atom directly attached in position 7

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
AU86367/98A 1997-07-31 1998-07-31 Pharmaceutical compounds isolated from aristolochia taliscana Abandoned AU8636798A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9716244 1997-07-31
GBGB9716244.0A GB9716244D0 (en) 1997-07-31 1997-07-31 Pharmaceutical compounds
PCT/GB1998/002317 WO1999006388A2 (en) 1997-07-31 1998-07-31 Pharmaceutical compounds isolated from aristolochia taliscana

Publications (1)

Publication Number Publication Date
AU8636798A true AU8636798A (en) 1999-02-22

Family

ID=10816797

Family Applications (1)

Application Number Title Priority Date Filing Date
AU86367/98A Abandoned AU8636798A (en) 1997-07-31 1998-07-31 Pharmaceutical compounds isolated from aristolochia taliscana

Country Status (5)

Country Link
EP (1) EP1027344A2 (en)
AU (1) AU8636798A (en)
CA (1) CA2298677A1 (en)
GB (1) GB9716244D0 (en)
WO (1) WO1999006388A2 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1117415A1 (en) * 1998-07-31 2001-07-25 Proteome Sciences Plc Use of extracts from aristolochia in the treatment of aids
US8246969B2 (en) 2001-11-16 2012-08-21 Skinmedica, Inc. Compositions containing aromatic aldehydes and their use in treatments
US7662821B2 (en) 2003-10-08 2010-02-16 Bayer Schering Pharma Ag Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
US7638515B2 (en) 2003-10-08 2009-12-29 Bayer Schering Pharma Aktiengesellschaft Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
NZ546473A (en) 2003-10-08 2009-09-25 Bayer Schering Pharma Ag 1-amino-2-oxy-substituted tetrahydronaphthalene derivatives, methods for the production thereof, and their use as antiphlogistics
US20080153859A1 (en) 2004-04-05 2008-06-26 Hartmut Rehwinkel Multiply-substituted tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
JP4568527B2 (en) * 2004-04-22 2010-10-27 ポーラ化成工業株式会社 Benzofuran derivative and external preparation for skin containing the same
DE102005017316A1 (en) * 2005-04-14 2006-10-19 Schering Ag Tetrahydronaphthalene derivatives, process for their preparation and their use as anti-inflammatory agents
EP1834948A1 (en) 2006-03-15 2007-09-19 Bayer Schering Pharma Aktiengesellschaft Tetrahydronaphtalene derivatives, methods for the production thereof, and their use as antiinflammatory drugs
KR101778654B1 (en) 2010-04-08 2017-09-14 시므라이즈 아게 Use of Dihydrodehydrodiisoeugenol and preparations comprising Dihydrodehydrodiisoeugenol
EP2655362A1 (en) 2010-12-22 2013-10-30 Abbvie Inc. Hepatitis c inhibitors and uses thereof
SG10201602752XA (en) 2011-01-07 2016-05-30 Allergan Inc Melanin modification compositions and methods of use
US11066378B2 (en) * 2015-06-04 2021-07-20 Taipei Medical University Caffeic acid derivatives for anti-angiogenesis
CN109721580B (en) * 2017-10-27 2022-11-04 中国医学科学院药物研究所 3-phenyl-7, 8-dehydrograpevine derivatives, preparation method, pharmaceutical composition and use thereof
CN109721579B (en) * 2017-10-27 2022-11-04 中国医学科学院药物研究所 7, 8-dehydrograpevine derivatives, preparation method, pharmaceutical composition and use thereof
CN117402196A (en) * 2022-09-13 2024-01-16 中国科学院脑科学与智能技术卓越创新中心 Antitumor active compound and preparation method and application thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3481944A (en) * 1968-11-01 1969-12-02 Sterling Drug Inc Certain aryl and hetero aryl oximes and 4-benzoyloxycyclohexanone oxime
US3745218A (en) * 1971-03-26 1973-07-10 Us Agriculture Preservation process using 2-(4-hydroxyphenyl)-benzofuran
US3917654A (en) * 1973-06-08 1975-11-04 Riku Lab Inc Anti-inflammatory substituted benzofuran
JPS62126128A (en) * 1985-11-27 1987-06-08 Sato Seiyaku Kk External preparation composition
US4714711A (en) * 1986-11-05 1987-12-22 Merck & Co., Inc. 6-hydroxy-2(2-hydroxy-4-methoxyphenyl)benzofuran derivatives to inhibit leukotriene biosynthesis
JPS63167791A (en) * 1986-12-27 1988-07-11 Kanebo Ltd Mutation inhibitor
EP0295851A1 (en) * 1987-06-18 1988-12-21 Merck Frosst Canada Inc. 4,7-diacyloxybenzofuran derivatives
US4782077A (en) * 1987-08-20 1988-11-01 Monoclonetics International, Inc. Taliscanin and other aristolactams for treating neurological disorders, Parkinson's disease, Alzheimer disease and impotence
JP2660969B2 (en) * 1988-06-06 1997-10-08 鐘紡株式会社 Benzofuranyl propenoic acid derivative
JP2746453B2 (en) * 1990-03-13 1998-05-06 鐘紡株式会社 Active oxygen scavenger
ES2072416T3 (en) * 1990-07-05 1995-07-16 Indena Spa NEOLIGNAN DERIVATIVE COMPLEXES WITH PHOSPHOLIPIDS, THEIR USE AND PHARMACEUTICAL AND COSMETIC FORMULATIONS CONTAINING THEM.
DE4117512A1 (en) * 1991-05-25 1992-11-26 Schering Ag 2-PHENYLBENZO (B) FURANES AND THIOPHENES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM
JPH09124632A (en) * 1995-10-31 1997-05-13 Sankyo Co Ltd Benzo-heterocyclic derivative
JPH09176074A (en) * 1995-12-28 1997-07-08 Kibun Foods Inc Antimicrobial, antifungal and anti-inflammatory active substance and production thereof

Also Published As

Publication number Publication date
CA2298677A1 (en) 1999-02-11
EP1027344A2 (en) 2000-08-16
GB9716244D0 (en) 1997-10-08
WO1999006388A8 (en) 2000-06-15
WO1999006388A2 (en) 1999-02-11
WO1999006388A3 (en) 1999-04-22

Similar Documents

Publication Publication Date Title
AU1225000A (en) Combined pharmaceutical estrogen-androgen-progestin
AU1151099A (en) Azaoxindole derivatives
AU1825899A (en) Dota-biotin derivatives
AU7935398A (en) Diaminorhodamine derivatives
AU6117998A (en) 3-oxadiazolylquinoxaline derivatives
AU6740298A (en) Pharmaceutical composition
GB9700504D0 (en) Pharmaceutical compounds
AU5387898A (en) Pharmaceutical agents
AU2533495A (en) Pharmaceutical diketopiperazine compounds
AU6804098A (en) Triazinylaminostilbene compounds
AU8636798A (en) Pharmaceutical compounds isolated from aristolochia taliscana
AU6904896A (en) Pharmaceutical compounds
AU8107998A (en) Pharmaceutical compositions
AU8591898A (en) Pharmaceutical compounds
AU1409100A (en) Drugs
AU7476598A (en) 18-substituted-19-nor-vitamin d compounds
AU4330097A (en) Pharmaceutical compounds
AU9343098A (en) Pharmaceutical composition
AU1174199A (en) Biphenylamidine derivatives
AU6729498A (en) Thiazolimine derivatives
AU7124598A (en) Polymer-platinum compounds
AU4169897A (en) Pharmaceutical compounds
AU6480299A (en) Pharmaceutical compounds
AU3467197A (en) Tetracyclical derivatives from pyrimidine
ZA98300B (en) Pharmaceutical compounds

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase